Onconetix, Inc.
201 E. Fifth Street, Suite 1900
Cincinnati, OH 45202
VIA EDGAR
February 10, 2025
U.S. Securities and Exchange Commission
Office of Life Sciences
Washington, D.C. 20549
Attn: Jessica Dickerson
| Re: | Onconetix, Inc. | ||
| Registration Statement on Form S-1 | |||
| Filed January 27, 2025 | |||
| File No. 333-284507 |
Ladies and Gentleman,
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Onconetix, Inc. hereby requests acceleration of effectiveness of the above referenced Registration Statement so that it will become effective at 5:00 p.m. EST on Tuesday, February 11, 2025, or as soon as thereafter practicable.
| Very truly yours, |
| /s/ Karina Fedasz |
| By: Karina Fedasz |
| Title: Interim Chief Financial Officer |
| cc: | Ellenoff Grossman & Schole LLP |